Background: Patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) require immunosuppressive therapy for disease control and reduction of relapse may be at risk complications during Sars-CoV-2 (COVID-19) infection. Objectives: To analyze the consequences COVID-19 in a large cohort AAV patients regarding occurrence, need hospitalization, treatment intensive care un...
